A Pennsylvania federal judge said last month that he would approve a $512 million settlement between direct purchasers and Teva Pharmaceutical Industries Ltd. and its subsidiaries Cephalon I... Read more
Teva Pharmaceutical Industries Ltd. and subsidiaries Cephalon Inc. and Barr Pharmaceuticals Inc. have agreed to pay $512 million to settle with the direct purchasers in pay-for-delay litigat... Read more
One of the Federal Trade Commission’s (FTC) top priorities in recent years has been to litigate a costly legal tactic that more and more branded drug manufacturers have been using to stifle... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.